Skip to main content
Clinical Trials/NCT01048281
NCT01048281
Recruiting
Not Applicable

Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

Stanford University1 site in 1 country100 target enrollmentAugust 1, 2002

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stomach Cancer
Sponsor
Stanford University
Enrollment
100
Locations
1
Primary Endpoint
p53 activity by routine pathologic analysis
Status
Recruiting
Last Updated
4 months ago

Overview

Brief Summary

Our research of the biology of upper gastrointestinal cancers involves the study of tissue samples and cells from biopsies of persons with gastric or esophageal cancer or blood samples from upper gastrointestinal cancer patients and persons at high inherited risk for these cancers. We hope to learn the role genes and proteins play in the development of gastric and esophageal cancer.

Registry
clinicaltrials.gov
Start Date
August 1, 2002
End Date
January 1, 2099
Last Updated
4 months ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with gastric or esophageal cancer OR at an increased hereditary risk for upper GI cancer

Exclusion Criteria

  • No family or personal history of gastric or esophageal cancer

Outcomes

Primary Outcomes

p53 activity by routine pathologic analysis

Time Frame: time of collection

NER activity by routine pathologic analysis

Time Frame: time of collection

Study Sites (1)

Loading locations...

Similar Trials